| scholarly article | Q13442814 |
| P50 | author | Paolo Fusar-Poli | Q21094931 |
| Ruth L O'Gorman | Q37373470 | ||
| Paul Allen | Q37834596 | ||
| Philip McGuire | Q37834611 | ||
| Sagnik Bhattacharyya | Q43272523 | ||
| James Stone | Q43280374 | ||
| Marc L Seal | Q47701711 | ||
| David Lythgoe | Q50063939 | ||
| Andrea Mechelli | Q60062761 | ||
| Isabel Valli | Q114386357 | ||
| P2093 | author name string | Marie Raffin | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 97-99 | |
| P577 | publication date | 2010-10-30 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis. | |
| P478 | volume | 69 |
| Q35663157 | Altered resting state complexity in schizophrenia |
| Q38621565 | Can neuroimaging be used to predict the onset of psychosis? |
| Q33635658 | Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study |
| Q62725703 | Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis |
| Q38060256 | Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?--A systematic review of structural and functional brain abnormalities. |
| Q57403237 | Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis |
| Q64267299 | Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis |
| Q92388753 | Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG |
| Q30845062 | Glutamate-mediated excitotoxicity in schizophrenia: a review |
| Q30732395 | Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings |
| Q90826039 | Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis |
| Q30385677 | Identifying Individuals at High Risk of Psychosis: Predictive Utility of Support Vector Machine using Structural and Functional MRI Data. |
| Q30685335 | Imaging glutamate in schizophrenia: review of findings and implications for drug discovery |
| Q28083121 | In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia |
| Q50420976 | Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC. |
| Q39218958 | Lasting modulation effects of rTMS on neural activity and connectivity as revealed by resting-state EEG. |
| Q48723751 | Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia |
| Q34400977 | Multimodal functional and structural imaging investigations in psychosis research |
| Q90750994 | Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome |
| Q37228333 | Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis |
| Q34552937 | Neuroimaging findings in the at-risk mental state: a review of recent literature |
| Q41151767 | Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder |
| Q104064767 | Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis |
| Q30712278 | Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis |
| Q55105831 | Structural and functional alterations in the brain during working memory in medication-naïve patients at clinical high-risk for psychosis. |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q89925235 | The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies |
| Q26860217 | Translating the MAM model of psychosis to humans |
Search more.